Reviewing Container Closure Systems in Regulatory Submissions
Container Closure Systems (CCS) are integral to pharmaceutical product integrity and must be adequately justified in regulatory submissions. Agencies such as the FDA, EMA, and CDSCO closely examine packaging sections within the Common Technical Document (CTD), especially Module 3. This article details how to prepare, structure, and present container closure data for stability studies in…
Read More “Reviewing Container Closure Systems in Regulatory Submissions” »